PharmaCyte Biotech, Inc. Common Stock (PMCB)

Typically moves ±0.42% on earnings
EARNINGS ANALYTICS
search

PharmaCyte Biotech, Inc. Common Stock (PMCB) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -0.42% (Jul 11, 2022) and its biggest decline was -0.42% (Jul 11, 2022).

Earnings reactions

How PMCB moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±0.42%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Jul 11, 2022 ☽ POST -0.42% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.42%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 3 →
3
Funds holding
$23691
Total value held
Selling
0 added · 1 reduced
Northern Trust Corp
$23689 Held
Blackrock, Inc.
$1 Held
Morgan Stanley
$1 -50.00%

SEC Filing Types

Recent SEC Filings

4 most recent
Form Date Filed View on EDGAR
4/A 20260717 open_in_new SEC.gov
4/A 20260717 open_in_new SEC.gov
4/A 20260717 open_in_new SEC.gov
4/A 20260717 open_in_new SEC.gov

Frequently asked about PMCB earnings

How much does PMCB stock move after earnings? expand_more

Over 1 reports, PMCB has moved an average of ±0.42% the session after earnings, closing higher 0.0% of the time.

What was PMCB's biggest post-earnings move? expand_more

PMCB's largest post-earnings gain on record was -0.42% on Jul 11, 2022, and its largest decline was -0.42% on Jul 11, 2022.

Where can I find PharmaCyte Biotech, Inc. Common Stock's SEC filings? expand_more

All of PharmaCyte Biotech, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers